Literature DB >> 31758238

Scutellariae radix and coptidis rhizoma ameliorate glycolipid metabolism of type 2 diabetic rats by modulating gut microbiota and its metabolites.

Suwei Xiao1, Chen Liu1, Mengjun Chen1, Junfeng Zou1, Zhimiao Zhang1, Xiang Cui1, Shu Jiang2, Erxin Shang1, Dawei Qian1, Jinao Duan3.   

Abstract

Scutellariae radix (Scutellaria baicalensis Georgi, SR) and coptidis rhizoma (Coptis chinensis Franch, CR) are both widely used traditional Chinese medicines and have been used together to treat T2DM with synergistic effects in the clinical practices for thousands of years, but their combination mechanism is not clear. Accumulating evidences have implicated gut microbiota as important targets for the therapy of T2DM. Thus, this study aimed to unravel the cooperation mechanism of SR and CR on the amelioration of T2DM based on the systematic analysis of metagenome and metabolome of gut microbiota. Bacterial communities were analyzed based on high-throughput 16S rRNA gene sequencing. Furthermore, ultra high-performance liquid chromatography coupled with quadrupole time of flight mass spectrometry (UPLC-Q-TOF-MS) was used to analyze variations of microbial metabolites in feces and the contents of short chain fatty acids (SCFAs) in the cecum were determined by a gaschromatography-flame ionization detector (GC-FID). 16S rRNA gene sequencing results revealed that T2DM rats treated with SR, CR, and the combination of SR and CR (SC) exhibited changes in the composition of the gut microbiota. The SCFAs-producing bacteria such as Bacteroidales S24-7 group_norank, [Eubacterium] nodatum group, Parasutterella, Prevotellaceae UCG-001, Ruminiclostridium, and Ruminiclostridium 9 in T2DM rats were notably enriched after treatment with SR, CR, and their combination. In contrast, secondary bile acid-producing bacteria such as Escherichia-Shigella strongly decreased in numbers. The perturbance of metabolic profiling in T2DM rats was obviously improved after treatment, exhibiting a lower level of secondary bile acids and a numerical increase of microbially derived SCFAs. Moreover, the correlation analysis illustrated a close relationship among gut microbiota, its metabolites, and T2DM-related indexes. The findings indicated that the crosstalk between microbiota-derived metabolites and the host played an important role in the progress of T2DM and might provide a novel insight regarding gut microbiota and its metabolites as potential new targets of traditional Chinese medicines. Furthermore, this work also suggested that the integration of various omics methods and bioinformatics made a useful template for drug mechanism research.

Entities:  

Keywords:  Coptidis rhizoma; Glycolipid metabolism; Gut microbiota; Scutellariae radix; Synergy; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31758238     DOI: 10.1007/s00253-019-10174-w

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  20 in total

1.  The storage stability of Bacillus subtilis spore displaying cysteine protease of Clonorchis sinensis and its effect on improving the gut microbiota of mice.

Authors:  Zeli Tang; Zhanshuai Wu; Hengchang Sun; Lu Zhao; Mei Shang; Mengchen Shi; Hongye Jiang; Zhipeng Lin; Xinyi Zhou; Xuerong Li; Xinbing Yu; Yan Huang
Journal:  Appl Microbiol Biotechnol       Date:  2021-02-19       Impact factor: 4.813

Review 2.  Gut microbiota: a new avenue to reveal pathological mechanisms of constipation.

Authors:  Lei Yang; Yu Wang; Yun Zhang; Wenwen Li; Shu Jiang; Dawei Qian; Jinao Duan
Journal:  Appl Microbiol Biotechnol       Date:  2022-10-03       Impact factor: 5.560

3.  Potential Mechanism of S. baicalensis on Lipid Metabolism Explored via Network Pharmacology and Untargeted Lipidomics.

Authors:  Ping-Yuan Ge; Yi-Yu Qi; Shu-Yue Qu; Xin Zhao; Sai-Jia Ni; Zeng-Ying Yao; Rui Guo; Nian-Yun Yang; Qi-Chun Zhang; Hua-Xu Zhu
Journal:  Drug Des Devel Ther       Date:  2021-05-04       Impact factor: 4.162

4.  Yiqi Jiedu Huayu Decoction Alleviates Renal Injury in Rats With Diabetic Nephropathy by Promoting Autophagy.

Authors:  Chen Xuan; Yu-Meng Xi; Yu-Di Zhang; Chun-He Tao; Lan-Yue Zhang; Wen-Fu Cao
Journal:  Front Pharmacol       Date:  2021-04-12       Impact factor: 5.810

5.  Ramulus Mori (Sangzhi) Alkaloids (SZ-A) Ameliorate Glucose Metabolism Accompanied by the Modulation of Gut Microbiota and Ileal Inflammatory Damage in Type 2 Diabetic KKAy Mice.

Authors:  Quan Liu; Shuainan Liu; Hui Cao; Wenming Ji; Caina Li; Yi Huan; Lei Lei; Yaxin Fu; Xuefeng Gao; Yuling Liu; Zhufang Shen
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

6.  Effects of ultrasound on the degradation kinetics, physicochemical properties and prebiotic activity of Flammulina velutipes polysaccharide.

Authors:  Jinrong Xiao; Xin Chen; Qiping Zhan; Lei Zhong; Qiuhui Hu; Liyan Zhao
Journal:  Ultrason Sonochem       Date:  2021-12-28       Impact factor: 7.491

Review 7.  Natural Ingredients from Medicine Food Homology as Chemopreventive Reagents against Type 2 Diabetes Mellitus by Modulating Gut Microbiota Homoeostasis.

Authors:  Xiaoyan Xia; Jiao Xiao
Journal:  Molecules       Date:  2021-11-17       Impact factor: 4.411

8.  Mechanisms of Rhizoma Coptidis against type 2 diabetes mellitus explored by network pharmacology combined with molecular docking and experimental validation.

Authors:  Wenrong An; Yanqin Huang; Shouqiang Chen; Tao Teng; Yingning Shi; Zhenhai Sun; Yunsheng Xu
Journal:  Sci Rep       Date:  2021-10-21       Impact factor: 4.379

9.  Tilapia Head Protein Hydrolysate Attenuates Scopolamine-Induced Cognitive Impairment through the Gut-Brain Axis in Mice.

Authors:  Jun Ji; Xiangzhou Yi; Yujie Zhu; Hui Yu; Shuqi Huang; Zhongyuan Liu; Xueying Zhang; Guanghua Xia; Xuanri Shen
Journal:  Foods       Date:  2021-12-17

10.  Kudzu Resistant Starch: An Effective Regulator of Type 2 Diabetes Mellitus.

Authors:  Xinqi Song; Huanhuan Dong; Zhenzhong Zang; Wenting Wu; Weifeng Zhu; Hua Zhang; Yongmei Guan
Journal:  Oxid Med Cell Longev       Date:  2021-10-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.